Search Results - Schmeichel-Mueller, C

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    PSS26 Determining Accurate Dosing of Ustekinumab from Specialty Pharmacy Data

    PSS26 Determining Accurate Dosing of Ustekinumab from Specialty Pharmacy Data by Schmeichel-Mueller, C, Gunnarsson, C, Martin, S

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    PMS78 Analyzing the Difference in Health Care Costs of Rheumatoid Arthritis Patients Switching or Dose Escalating Anti-TNF Biologics Using Combined Propensity Score Matching and Multivariate Regression Model

    PMS78 Analyzing the Difference in Health Care Costs of Rheumatoid Arthritis Patients Switching or Dose Escalating Anti-TNF Biologics Using Combined Propensity Score Matching and Mu... by Baser, O, Schmeichel-mueller, C, Ingham, M

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    PMS53 Using Scatter Plots, Analysis of Univariate Relationship Between Confounders and Outcomes among Rheumatoid Arthritis Patients Who Initiated Anti-Tumor Necrosis Factors and Subsequently Switched or Escalated

    PMS53 Using Scatter Plots, Analysis of Univariate Relationship Between Confounders and Outcomes among Rheumatoid Arthritis Patients Who Initiated Anti-Tumor Necrosis Factors and Su... by Baser, O, Schmeichel-mueller, C, Ingham, M

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    PSS27 Relationship Between Weight and Dose in Psoriasis Patients Treated with Ustekinumab

    PSS27 Relationship Between Weight and Dose in Psoriasis Patients Treated with Ustekinumab by Schmeichel-Mueller, C, Goren, A, DiBonaventura, M.D, Martin, S

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    PMS61 INFLIXIMAB INFUSION PATTERNS IN PATIENTS WITH RHEUMATOID ARTHRITIS ‘NAïVE' TO BIOLOGIC THERAPY: AN ANALYSIS OF A NATIONAL HEALTH PLAN

    PMS61 INFLIXIMAB INFUSION PATTERNS IN PATIENTS WITH RHEUMATOID ARTHRITIS ‘NAïVE' TO BIOLOGIC THERAPY: AN ANALYSIS OF A NATIONAL HEALTH PLAN by Schmeichel-Mueller, C, Tkacz, J, Ruetsch, C

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    MC1 COMPARISON OF REFILL GAP ANALYSIS METHODOLOGIES IN A POPULATION OF PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ADALIMUMAB OR ETANERCEPT

    MC1 COMPARISON OF REFILL GAP ANALYSIS METHODOLOGIES IN A POPULATION OF PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ADALIMUMAB OR ETANERCEPT by Carter, C, Bolge, S, Ingham, M, Schmeichel-Mueller, C

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    PSY68 DEFINITIONS OF ANTI-TNF DISCONTINUATION MAY IMPACT UNDERSTANDING OF REAL-WORLD UTILIZATION PATTERNS

    PSY68 DEFINITIONS OF ANTI-TNF DISCONTINUATION MAY IMPACT UNDERSTANDING OF REAL-WORLD UTILIZATION PATTERNS by Schmeichel-Mueller, C, Buysman, E, Bolge, S, Ingham, M, McKenzie, R.S

    Published in Value in health
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    PMS67 FREQUENCY OF SELECT ANTI-TNF ADMINISTRATION OR RE-FILL IN PATIENTS WITH RHEUMATOID ARTHRITIS

    PMS67 FREQUENCY OF SELECT ANTI-TNF ADMINISTRATION OR RE-FILL IN PATIENTS WITH RHEUMATOID ARTHRITIS by Schmeichel-Mueller, C, Bartels, A, Silver, J, Bolge, S, Ingham, M

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    PMS7 COST ANALYSIS OF RECENTLY APPROVED AND OLDER ANTI-TNF BIOLOGIC AGENTS USED IN RHEUMATOID ARTHRITIS

    PMS7 COST ANALYSIS OF RECENTLY APPROVED AND OLDER ANTI-TNF BIOLOGIC AGENTS USED IN RHEUMATOID ARTHRITIS by Carter, C, Schmeichel-Mueller, C, McKenzie, RS, Piech, CT

    Published in Value in health
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: